vs
DYNAVAX TECHNOLOGIES CORP（DVAX）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
DYNAVAX TECHNOLOGIES CORP的季度营收约是REPUBLIC BANCORP INC的1.0倍（$94.9M vs $94.3M），DYNAVAX TECHNOLOGIES CORP净利率更高（28.4% vs 24.2%，领先4.2%），DYNAVAX TECHNOLOGIES CORP同比增速更快（17.7% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $32.6M），过去两年DYNAVAX TECHNOLOGIES CORP的营收复合增速更高（30.6% vs -11.5%）
Dynavax Technologies Corp是一家处于商业化阶段的生物制药企业，专注于研发和生产针对传染病的创新疫苗及免疫疗法，核心上市产品为成人乙肝疫苗Heplisav-B，主要市场覆盖北美与欧洲，同时拥有多款针对未满足公共卫生需求的在研产品。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
DVAX vs RBCAA — 直观对比
营收规模更大
DVAX
是对方的1.0倍
$94.3M
营收增速更快
DVAX
高出12.4%
5.3%
净利率更高
DVAX
高出4.2%
24.2%
自由现金流更多
RBCAA
多$128.5M
$32.6M
两年增速更快
DVAX
近两年复合增速
-11.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.9M | $94.3M |
| 净利润 | $26.9M | $22.8M |
| 毛利率 | — | — |
| 营业利润率 | 22.4% | 29.3% |
| 净利率 | 28.4% | 24.2% |
| 营收同比 | 17.7% | 5.3% |
| 净利润同比 | 53.0% | 20.0% |
| 每股收益（稀释后） | $0.21 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DVAXRBCAA
| Q4 25 | — | $94.3M | ||
| Q3 25 | $94.9M | $93.5M | ||
| Q2 25 | $95.4M | $93.8M | ||
| Q1 25 | $68.2M | $135.8M | ||
| Q4 24 | $72.0M | $89.5M | ||
| Q3 24 | $80.6M | $88.1M | ||
| Q2 24 | $73.8M | $86.9M | ||
| Q1 24 | $50.8M | $120.3M |
净利润DVAXRBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $26.9M | $29.7M | ||
| Q2 25 | $18.7M | $31.5M | ||
| Q1 25 | $-96.1M | $47.3M | ||
| Q4 24 | $7.0M | $19.0M | ||
| Q3 24 | $17.6M | $26.5M | ||
| Q2 24 | $11.4M | $25.2M | ||
| Q1 24 | $-8.7M | $30.6M |
营业利润率DVAXRBCAA
| Q4 25 | — | 29.3% | ||
| Q3 25 | 22.4% | 40.4% | ||
| Q2 25 | 15.1% | 43.0% | ||
| Q1 25 | -34.7% | 44.1% | ||
| Q4 24 | -2.3% | 25.8% | ||
| Q3 24 | 12.5% | 38.4% | ||
| Q2 24 | 7.0% | 37.0% | ||
| Q1 24 | -35.0% | 32.2% |
净利率DVAXRBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | 28.4% | 31.8% | ||
| Q2 25 | 19.6% | 33.5% | ||
| Q1 25 | -141.0% | 34.8% | ||
| Q4 24 | 9.8% | 21.2% | ||
| Q3 24 | 21.8% | 30.1% | ||
| Q2 24 | 15.4% | 29.0% | ||
| Q1 24 | -17.2% | 25.4% |
每股收益（稀释后）DVAXRBCAA
| Q4 25 | — | — | ||
| Q3 25 | $0.21 | — | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | $-0.77 | — | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $534.1M | $1.1B |
| 总资产 | $946.5M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DVAXRBCAA
| Q4 25 | — | $220.0M | ||
| Q3 25 | $160.2M | $484.2M | ||
| Q2 25 | $99.1M | $484.8M | ||
| Q1 25 | $51.7M | $793.0M | ||
| Q4 24 | $95.9M | $432.2M | ||
| Q3 24 | $119.3M | $530.9M | ||
| Q2 24 | $112.5M | $400.1M | ||
| Q1 24 | $132.0M | $546.4M |
股东权益DVAXRBCAA
| Q4 25 | — | $1.1B | ||
| Q3 25 | $534.1M | $1.1B | ||
| Q2 25 | $494.2M | $1.1B | ||
| Q1 25 | $530.9M | $1.0B | ||
| Q4 24 | $596.8M | $992.0M | ||
| Q3 24 | $681.4M | $979.7M | ||
| Q2 24 | $642.8M | $955.4M | ||
| Q1 24 | $618.5M | $935.6M |
总资产DVAXRBCAA
| Q4 25 | — | $7.0B | ||
| Q3 25 | $946.5M | $7.0B | ||
| Q2 25 | $918.4M | $7.0B | ||
| Q1 25 | $945.9M | $7.1B | ||
| Q4 24 | $986.3M | $6.8B | ||
| Q3 24 | $1.1B | $6.7B | ||
| Q2 24 | $1.0B | $6.6B | ||
| Q1 24 | $986.6M | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $161.1M |
| 自由现金流率自由现金流/营收 | 34.4% | 170.9% |
| 资本支出强度资本支出/营收 | 1.3% | 7.5% |
| 现金转化率经营现金流/净利润 | 1.26× | 7.37× |
| 过去12个月自由现金流最近4个季度 | $80.5M | $288.6M |
8季度趋势，按日历期对齐
经营现金流DVAXRBCAA
| Q4 25 | — | $168.2M | ||
| Q3 25 | $33.8M | $33.3M | ||
| Q2 25 | $23.4M | $8.4M | ||
| Q1 25 | $-19.6M | $93.2M | ||
| Q4 24 | $53.0M | $149.0M | ||
| Q3 24 | $19.5M | $51.3M | ||
| Q2 24 | $10.7M | $4.0M | ||
| Q1 24 | $-16.7M | $71.2M |
自由现金流DVAXRBCAA
| Q4 25 | — | $161.1M | ||
| Q3 25 | $32.6M | $30.8M | ||
| Q2 25 | $22.0M | $5.2M | ||
| Q1 25 | $-23.6M | $91.6M | ||
| Q4 24 | $49.5M | $143.2M | ||
| Q3 24 | $18.1M | $49.8M | ||
| Q2 24 | $9.9M | $2.7M | ||
| Q1 24 | $-17.4M | $69.1M |
自由现金流率DVAXRBCAA
| Q4 25 | — | 170.9% | ||
| Q3 25 | 34.4% | 32.9% | ||
| Q2 25 | 23.0% | 5.5% | ||
| Q1 25 | -34.6% | 67.4% | ||
| Q4 24 | 68.8% | 160.0% | ||
| Q3 24 | 22.5% | 56.5% | ||
| Q2 24 | 13.5% | 3.1% | ||
| Q1 24 | -34.3% | 57.5% |
资本支出强度DVAXRBCAA
| Q4 25 | — | 7.5% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 1.5% | 3.5% | ||
| Q1 25 | 5.8% | 1.2% | ||
| Q4 24 | 4.8% | 6.5% | ||
| Q3 24 | 1.7% | 1.7% | ||
| Q2 24 | 1.1% | 1.5% | ||
| Q1 24 | 1.5% | 1.7% |
现金转化率DVAXRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | 1.26× | 1.12× | ||
| Q2 25 | 1.25× | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | 7.52× | 7.84× | ||
| Q3 24 | 1.11× | 1.93× | ||
| Q2 24 | 0.94× | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
RBCAA
暂无分部数据
